Peer Review History
| Original SubmissionJune 24, 2024 |
|---|
|
PONE-D-24-25313Using youth-engaged research methods to develop a measure of disordered eating in transgender, non-binary, and gender-diverse youth: research protocolPLOS ONE Dear Dr. Pham, Thank you for submitting your research protocol to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the protocol that addresses the points raised during the review process. Please submit your revised protocol by Sep 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your protocol file. Please include the following items when submitting your revised protocol:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised protocol. Kind regards, Christina M. Roberts, M.D., M.P.H. Academic Editor PLOS ONE Journal requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent will be informed and (2) what type you obtain (for instance, written or verbal, and if verbal, how it will be documented and witnessed). If your study includes minors, state whether you obtain consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Thank you for stating the following financial disclosure: [Dr. Pham acknowledges her support by NIH/NIMH K23 MH134111. The project is in part also supported by CTSA award No. UM1TR004360 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. ]. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 5. Thank you for stating the following in the Acknowledgments Section of your manuscript: [Dr. Pham acknowledges her support by NIH/NIMH K23 MH134111. The project is in part also supported by CTSA award No. UM1TR004360 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.] We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [Dr. Pham acknowledges her support by NIH/NIMH K23 MH134111. The project is in part also supported by CTSA award No. UM1TR004360 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. ] Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 6. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 7. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. Authors’ affiliations should reflect the institution where the work was done (if authors moved subsequently, you can also list the new affiliation stating “current affiliation:….” as necessary). 8. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 9. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate ""supporting information"" files". Additional Editor Comments: Thank you for submitting your research protocol for our review. The reviewers and I are excited about your proposed research. However, the reviewers have several suggestions and requests for clarification. I recommend considering these suggestions and revising your proposed protocol to address these concerns. Amongst other concerns, the reviewers suggested expanding your literature review and using this additional information to inform overall use of inclusive language, justification of your study, and your description of the qualitative methods you will be using. I have listed links to some of the resources suggested by our reviewers to facilitate access to these materials.
Reviewers would also like you to provide more details about your plans for:
I think your proposed study is important and will provide valuable insight for treatment and prevention efforts. I feel incorporating the feedback from our reviewers will further strengthen your study and the quality of the data you obtain. I look forward to reviewing your revision if you elect to revise and resubmit your protocol for further review. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses? The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable? Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thanks for taking on this research, it's important and sure to be impactful! I'll attach my comments in a PDF. Reviewer #2: See attachment for full review comments. This is an exciting study that addresses an important gap in the literature and the authors intend to maximize TNG youth involvement. However, important details are missing processes for community engagement and how compensation is determined, especially due to the amount of labor they are requesting from TNG youth. The methods for qualitative analysis are also underdeveloped and inconsistent with how Braun & Clarke’s approach to thematic analysis has evolved. There is no mention of reflexivity as part of the analytic process, which is particularly concerning considering the nature of the study. Citations throughout are also relatively old and many could be updated. Finally, more attention could be paid to language throughout. I am curious if excluding intersex youth from TNG is on purpose or an oversight. If the study intends to include intersex youth please modify sociodemographic information collected. Reviewer #3: The authors provide a well-planned study to address an area of need related to trans youth with DEBs. Overall, the protocol outlines a future study that could be very valuable and offer great progress in the field. There are a few areas that I believe could be strengthened and/or points that may need to be considered, as detailed below: - I would encourage the authors to consider the age range for inclusion criteria for the study in Phases 2-4 and/or further explain the rationale for the chosen upper age limit. Because much of the introduction is specifically focused on TNG minors and many DEB scales begin at 18 for adult versions, it is unclear how the limit of 21 was chosen in how the authors define “youth”. - Although Phase 2 is an important aspect of the study, it seems to be less connected to the other phases. Is there a reason the authors are interested in general barriers to TNG youth participation in research and not barriers to research for TNG youth with disordered eating? Might TNG youth experiencing DEBs have additional or specific barriers to participation that TNG youth without disordered eating may not have that would not be captured in Phase 2? - The authors discuss some barriers to research participation for TNG youth, particularly parental consent and non-supportive caregivers. Given the high risk of safety concerns for TNG youth that may be outed by any potential breach of confidentiality, the authors are asked to address how they plan to safeguard participant identity and anonymity, particularly during qualitative interviews. - Given community-based recommendations against collecting sex assigned at birth from trans participants unless absolutely necessary, the authors are asked to consider how they will collect demographic data and the extent to which sex assigned at birth versus gender is necessary for ensuring measurement invariance. - The authors are encouraged to discuss any established plans for future changes to the study protocol after the YAB is established and how input from the YAB on study design will be solicited and incorporated prior to moving forward with Phases 2-4. - Since the authors are planning to ask about medical affirmation during the sociodemographic survey, they are also encouraged to ask about participants’ desire to access such medical care. Not all trans and genderqueer individuals desire or seek out gender affirming medical care, so it may be important to understand medical affirmation in the context of each participant’s desire for such care. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Scout Silverstein Reviewer #2: No Reviewer #3: Yes: Bek Urban ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-24-25313R1Using youth-engaged research methods to develop a measure of disordered eating in transgender, non-binary, and gender-diverse youth: research protocolPLOS ONE Dear Dr. Pham, Thank you for submitting your revised protocol to PLOS ONE. I think it is much improved and I am eager to see the results of your study. However, there are a four suggestions raised by the reviewers that I would like you to consider. Please address the following structural concerns with your protocol: 1. Compensation of research participants for their time: “provide rationale for compensating members of the YAB in a lump-sum every 6 months as opposed to after every meeting, especially given the prevalence of financial disparities for trans youth and the length of time between meetings and payment. . . . consider implications for retention of YAB members and how financial barriers may result in a lack of diversity among the YAB if compensation for time provided is only awarded twice per year.” 2. Plan for Human Subjects Protections: “provide any additional information related to planned recording of the interviews, methods and timeline for transcription of recordings, and how/when interview transcripts will be de-identified and unlinked from recordings” Please consider how your research participants, potential funders, reviewers, readers, will perceive the following decisions: 3. Use of the more common term "transphobia" versus the less common but more accurate cis-sexism: “I would encourage the authors to move away from the use of "transphobic discrimination" to "cissexism", as the latter term explicitly names the system of oppression driving discrimination against trans individuals and not a phobia of trans people.” 4: Collection of sex assigned at birth in a study of transgender and gender-diverse individuals who do not identify with their sex assigned at birth: "I would encourage the authors to continue considering the need for collection of sex in Phase 4, in combination with Reviewer 1's suggestion to collect data regarding intersex status. Although measurement invariance is important, it remains unclear to me if asking participants about their sex assigned at birth is meaningful enough to offset potential impacts and not honor community-based recommendations. Will testing invariance by sex be limited to a male/female binary, and if so, how do the authors plan to include intersex individuals? Finally, do the authors have other theoretical rationale for including sex assigned at birth aside from capacity to menstruate? Due to variation in onset of puberty, use of birth control, and other factors, not all individuals who are assigned female at birth can or do menstruate. If the concern about measurement variance is only tied to menstruation, I would encourage authors to consider how to collect information about menstruation specifically." You do not need to change your protocol based on suggestions 3 and 4, but I would like you to give thought to the feedback from the reviewers on these decisions. The full text of the reviewer's feedback is listed below. Please include the following items when submitting your revised protocol:
Please submit your revised manuscript by Dec 10 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. We look forward to receiving your revised protocol. Kind regards, Christina M. Roberts, M.D., M.P.H. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field. Reviewer #2: Yes Reviewer #3: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses? The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable? Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible. Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors have significantly improved the manuscript by providing further detail on methods, further engaging with the literature, and providing further details. There are several areas where the language is not as concise as it could be (e.g. using "as a result of" instead of "due to", "not recreate" instead of "avoid"), and sentences are quite long/meandering e.g., lines 69-75 (could be changed to something like "although prevalence rates of gender diverse identities vary significantly across surveys, trans femme people are underrepresented in eating disorder research (cite). It is important to address this gap because..."). I'm also not sure about the language "biased towards" in line 173. I recognize that some of this is a style preference, but I do think that further editing could improve readability throughout. Reviewer #3: I appreciate the changes made by the authors and their responsiveness to reviews. I have a few other points of feedback for the authors: Abstract 1. In response to other reviewers, the authors made edits in lines 4-7. The edits more clearly frame factors related DEB among TNG youth. I would encourage the authors to move away from the use of "transphobic discrimination" to "cissexism", as the latter term explicitly names the system of oppression driving discrimination against trans individuals and not a phobia of trans people. Materials and Methods 1. The authors added information about payment for each phase of the study. Phase 1 notes that the YAB will be paid $250 for every 6 months of participation. The authors are asked to provide rationale for compensating members of the YAB in a lump-sum every 6 months as opposed to after every meeting, especially given the prevalence of financial disparities for trans youth and the length of time between meetings and payment. The authors are also asked to consider implications for retention of YAB members and how financial barriers may result in a lack of diversity among the YAB if compensation for time provided is only awarded twice per year. 2. I thank the authors for adding information about protecting interviewees. I would encourage the authors to provide any additional information related to planned recording of the interviews, methods and timeline for transcription of recordings, and how/when interview transcripts will be de-identified and unlinked from recordings, as recordings carry the highest level of risk for participants. Inclusion/Exclusion criteria: 1. Thank you for this update. The authors are still asked to respond to how studies reviewed in the introduction that focus on minors apply to TNG individuals who are 18-21 and any additional considerations for this age group that is to be included in the study. Data collection 1. I would encourage the authors to continue considering the need for collection of sex in Phase 4, in combination with Reviewer 1's suggestion to collect data regarding intersex status. Although measurement invariance is important, it remains unclear to me if asking participants about their sex assigned at birth is meaningful enough to offset potential impacts and not honor community-based recommendations. Will testing invariance by sex be limited to a male/female binary, and if so, how do the authors plan to include intersex individuals? Finally, do the authors have other theoretical rationale for including sex assigned at birth aside from capacity to menstruate? Due to variation in onset of puberty, use of birth control, and other factors, not all individuals who are assigned female at birth can or do menstruate. If the concern about measurement variance is only tied to menstruation, I would encourage authors to consider how to collect information about menstruation specifically. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: Yes: Bek Urban ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Using youth-engaged research methods to develop a measure of disordered eating in transgender, non-binary, and gender-diverse youth: research protocol PONE-D-24-25313R2 Dear Dr. Pham, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Christina M. Roberts, M.D., M.P.H. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-25313R2 PLOS ONE Dear Dr. Pham, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Christina M. Roberts Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .